Lilly to Spend $27 Billion to Bolster US Drug Manufacturing

Published on February 26, 2025

Eli Lilly & Co. will spend at least $27 billion to build four US manufacturing plants, the latest company to brace for the potential impact of President Donald Trump’s tariffs.